Parnassus Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Parnassus Investments's LLY Position: Q2 2026 in Review
Parnassus Investments reduced its Eli Lilly (LLY) stake by 44% in Q2 2026, selling an estimated $419M and leaving 525,464 shares worth $630M. The position accounts for 1.68% of the portfolio, ranked #22.
Parnassus Investments first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.09B in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Parnassus Investments held 525,464 shares of Eli Lilly worth $630M as of Q2 2026.
- Parnassus Investments sold 409,998 Eli Lilly shares in Q2 2026, an estimated $419M.
- Eli Lilly made up 1.68% of Parnassus Investments's portfolio in Q2 2026, its #22 holding.
- Parnassus Investments first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- Parnassus Investments's Eli Lilly position peaked at $1.09B in Q4 2025.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Parnassus Investments's 13F filing for Q2 2026, filed 29 Jul 2026.